mTOR signaling in renal ion transport
- PMID: 36906912
- DOI: 10.1111/apha.13960
mTOR signaling in renal ion transport
Abstract
The mammalian target of rapamycin (mTOR) signaling pathway is crucial in maintaining cell growth and metabolism. The mTOR protein kinase constitutes the catalytic subunit of two multimeric protein complexes called mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). As such, this pathway is indispensable for many organs, including the kidney. Since its discovery, mTOR has been associated with major renal disorders such as acute kidney injury, chronic kidney disease, and polycystic kidney disease. On top of that, emerging studies using pharmacological interventions and genetic disease models have unveiled mTOR role in renal tubular ion handling. Along the tubule, mTORC1 and mTORC2 subunits are ubiquitously expressed at mRNA level. Nevertheless, at the protein level, current studies suggest that a tubular segment-specific balance between mTORC1 and mTORC2 exists. In the proximal tubule, mTORC1 regulates nutrients transports through various transporters located in this segment. On the other hand, in the thick ascending limb of the loop of Henle, both complexes play a role in regulating NKCC2 expression and activity. Lastly, in the principal cells of the collecting duct, mTORC2 determines Na+ reabsorption and K+ excretion by regulating of SGK1 activation. Altogether, these studies establish the relevance of the mTOR signaling pathway in the pathophysiology of tubular solute transport. Despite extensive studies on the effectors of mTOR, the upstream activators of mTOR signaling remain elusive in most nephron segments. Further understanding of the role of growth factor signaling and nutrient sensing is essential to establish the exact role of mTOR in kidney physiology.
Keywords: electrolyte transport; kidney physiology; mammalian target of rapamycin; tubular disorder.
© 2023 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society.
Similar articles
-
Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct.Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F413-F416. doi: 10.1152/ajprenal.00170.2018. Epub 2018 May 30. Am J Physiol Renal Physiol. 2018. PMID: 29846113 Review.
-
Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases.Nat Rev Nephrol. 2023 Feb;19(2):102-122. doi: 10.1038/s41581-022-00648-y. Epub 2022 Nov 24. Nat Rev Nephrol. 2023. PMID: 36434160 Review.
-
Dynamic modeling of signal transduction by mTOR complexes in cancer.J Theor Biol. 2019 Dec 21;483:109992. doi: 10.1016/j.jtbi.2019.109992. Epub 2019 Sep 4. J Theor Biol. 2019. PMID: 31493485
-
Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1.PLoS Comput Biol. 2021 Sep 16;17(9):e1008513. doi: 10.1371/journal.pcbi.1008513. eCollection 2021 Sep. PLoS Comput Biol. 2021. PMID: 34529665 Free PMC article.
-
Using Drosophila melanogaster to Dissect the Roles of the mTOR Signaling Pathway in Cell Growth.Cells. 2023 Nov 14;12(22):2622. doi: 10.3390/cells12222622. Cells. 2023. PMID: 37998357 Free PMC article. Review.
Cited by
-
Unlocking the potential of stimuli-responsive biomaterials for bone regeneration.Front Pharmacol. 2024 Jul 31;15:1437457. doi: 10.3389/fphar.2024.1437457. eCollection 2024. Front Pharmacol. 2024. PMID: 39144636 Free PMC article. Review.
-
mTOR Signaling and Human Physiology Relevant to Kidney Disease.J Am Soc Nephrol. 2024 Jul 25;35(9):1139-40. doi: 10.1681/ASN.0000000000000450. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39053582 No abstract available.
-
mTOR Regulates Mineralocorticoid Receptor Transcriptional Activity by ULK1-Dependent and -Independent Mechanisms.Endocrinology. 2024 Feb 20;165(4):bqae015. doi: 10.1210/endocr/bqae015. Endocrinology. 2024. PMID: 38325289 Free PMC article.
References
REFERENCES
-
- Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960-976.
-
- Fantus D, Rogers NM, Grahammer F, Huber TB, Thomson AW. Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. Nat Rev Nephrol. 2016;12(10):587-609.
-
- Gui Y, Dai C. mTOR signaling in kidney diseases. Kidney360. 2020;1(11):1319-1327.
-
- Li J, Xu Z, Jiang L, et al. Rictor/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury. Kidney Int. 2014;86(1):86-102.
-
- Lieberthal W, Fuhro R, Andry C, Patel V, Levine JS. Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation. 2006;82(1):17-22.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous